Skip to main content
Caplight Logo









Peregrine Ophthalmic

Peregrine Ophthalmic

Private
SingaporeHealthcare & Life Scienceshttps://peregrineophthalmic.com/

Last Round

Grant

Mar 9, 2015

Total Funding Raised

$3M

Company Overview

Peregrine Ophthalmic is a biotechnology company that develops and delivers new solutions for the management of intraorbital and periorbital eye diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

nanomedicinedrug deliverysustained-releaseophthalmic drug deliveryglaucoma treatmentliposomal formulationbiotechlong-acting injectablesintraocular pressuredrug licensingophthalmologyclinical developmentdrug delivery platformpharma R&Deye disease

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Peregrine Ophthalmic Comparables

Compare Peregrine Ophthalmic with similar companies based on industry and business-model similarity.

Peregrine Ophthalmic comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PolyActiva
85%
Mati Therapeutics
77%
Ocular Therapeutix Inc
76%

Peregrine Ophthalmic Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 9, 2015
SeedAug 5, 2013

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 9, 2015

    Secured $3M in grant funding.

  • Aug 5, 2013

    Completed a Seed funding round.

Peregrine Ophthalmic Filings

Explore SEC and related filing metadata, where available.

Peregrine Ophthalmic filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Peregrine Ophthalmic's valuation, stock price, and market status.

Is Peregrine Ophthalmic a public or private company?

Peregrine Ophthalmic is a private company.

What is the current stock price of Peregrine Ophthalmic?

Peregrine Ophthalmic is a private company with no public stock price. Caplight tracks Peregrine Ophthalmic's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is Peregrine Ophthalmic worth (valuation)?

Valuation information for Peregrine Ophthalmic is not publicly available.

Can I buy Peregrine Ophthalmic stock?

Peregrine Ophthalmic shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Peregrine Ophthalmic's last funding round?

Peregrine Ophthalmic's most recent funding round was Grant on March 9, 2015.

Who are the main investors in Peregrine Ophthalmic?

Investor information for Peregrine Ophthalmic is not publicly disclosed.

Will Peregrine Ophthalmic IPO soon?

No public IPO plans have been announced for Peregrine Ophthalmic.

How can I track Peregrine Ophthalmic secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Peregrine Ophthalmic's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSingapore
Year Founded2013
Last FundingMar 9, 2015

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?